To help clinicians and patients determine if antibodies protect against reinfection, the ACP discussed tests for diagnosing and estimating the prevalence of COVID-19.
During weeks 12-19 of 2020, the incidence of end-stage kidney disease decreased 20% compared with the same period in 2017-2019, according to a COVID-19 supplement to the US Renal Data System 2020 annual data report.
Investigators collected survey data on demographics, risk perception, and death rate to assess their impact on voluntary behaviors, such as time spent at home.
In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”
Study authors assessed location of WNV outbreaks and associated neuroinvasive presentations for patterns.
Iin this study published in The Lancet Diabetes and Endocrinology, researchers evaluated whether the effects of vitamin D supplementation may reduce risk in acute respiratory infections.
The new report adds to growing evidence of COVID-19’s adverse effects on the kidneys.
Remdesivir is an investigational nucleotide analogue with broad-spectrum antiviral activity.
Research results underscore the importance of understanding the characteristics of Legionnaires’ disease and the need for early diagnosis.
Although children appear to be at low risk for COVID-19, data suggests that prolonged fecal viral shedding may position children as potential carriers of the virus.
